Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

The Use of Next Generation Gene Sequencing to Measure Minimal Residual Disease in Patients with AL Amyloidosis and Low Plasma Cell Burden: A Feasibility Study

Shayna Sarosiek, Vaishali Sanchorawala, MD, Mariateresa Fulcinti, Allison P. Jacob, Nikhil C. Munshi, MD, Cindy Varga, MD BSc

Blood (2019) 134 (Supplement_1): 4353.

https://doi.org/10.1182/blood-2019-131863

Published: 2019

Journal Articles

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

Vikram Premkumar, MD, Suzanne Lentzsch, MD PhD, Divaya Bhutani, MD

Blood (2019) 134 (Supplement_1): 3161.

https://doi.org/10.1182/blood-2019-123496

Published: 2019

Journal Articles

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

William J Archibald, MDCPA, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Curtis A. Hanson, MD, Wei Ding, MD PhD, Amber Koehler, PA-C, MS, Eli Muchtar, MD, Suzanne R. Hayman, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Yucai Wang, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD

Blood (2019) 134 (Supplement_1): 3037.

https://doi.org/10.1182/blood-2019-131154

Published: 2019

Journal Articles

Coexistence of B-Cell Dyscrasia with Large Granular Lymphocytic Leukemia

Hassan Awada, Jibran Durrani, Ashwin Kishtagari, MBBS, Valeria Visconte, PhD, Reda Z. Mahfouz, MD PhD

Blood (2019) 134 (Supplement_1): 3750.

https://doi.org/10.1182/blood-2019-132220

Published: 2019

Journal Articles

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis

Kristen Gonter-Aubin, DO, Daniel Alan Kerr, MD PhD, Ashley Rose, MD, Thanh Lana Nguyen, MDBS, Julio C. Chavez, MD, Javier Pinilla Ibarz, MD PhD

Blood (2019) 134 (Supplement_1): 1542.

https://doi.org/10.1182/blood-2019-129028

Published: 2019

Journal Articles

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Single-Institution Analysis

Daniel Alan Kerr, MD PhD, Kristen Gonter-Aubin, DO, Ashley Rose, MD, Thanh Lana Nguyen, Javier Pinilla Ibarz, MD, Julio C. Chavez, MD

Blood (2018) 132 (Supplement 1): 5323.

https://doi.org/10.1182/blood-2018-99-118386

Published: 2018

Journal Articles

Chimeric Antigen Receptor T-Cells for the Treatment of Gamma-Delta T-Cell Malignancies

Paul Maciocia, BSc, MBChB, MRCP, Patrycja Wawrzyniecka, Leo Kassimatis, Martin Pule, MD

Blood (2018) 132 (Supplement 1): 3338.

https://doi.org/10.1182/blood-2018-99-119774

Published: 2018

Journal Articles

Detection of Circulating Clonal Plasma Cells Using Next Generation Sequencing in Patients with AL Amyloidosis and Low Plasma Cell Burden: A Novel Discovery

Shayna Sarosiek, MD, Mariateresa Fulciniti, PhD, Allison Jacob, MS, Vaishali Sanchorawala, MD, Nikhil Munshi, MD, Cindy Varga, MD BSc

Blood (2017) 130 (Supplement 1): 5374.

https://doi.org/10.1182/blood.V130.Suppl_1.5374.5374

Published: 2017

Journal Articles

IGHV-D-J Repertoire Analysis Obtained By High-Throughput Sequencing of CD5+ B-Cells in CLL Patients: Prognostic Markers and Disease Development Implications

Davide Bagnara, PhD, Stefano Vergani, PhD, Andrea Nicola Mazzarello, PhD, Gerardo Ferrer, PhD, Franco Fais, PhD, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 54.

https://doi.org/10.1182/blood.V130.Suppl_1.54.54

Published: 2017

Journal Articles

Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease

Alexandra Nagy, MD, Aparna Bhaduri, Nahid Shahmarvand, MD, Jahanbanoo Shahryari, MD, James L. Zehnder, MD, Roger Warnke, MD, Tariq I Mughal, MD FRCP, Siraj M Ali, MD PhD, Robert S. Ohgami, MD PhD

Blood (2017) 130 (Supplement 1): 4016.

https://doi.org/10.1182/blood.V130.Suppl_1.4016.4016

Published: 2017

Journal Articles

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

Giuseppe Rossi, MD, Francesca Paoloni, Bruno Fattizzo, MD, Francesca Binda, MD, Mariella D'Adda, MD, Mirko Farina, MD, Cecilia Carbone, MD, Francesco Zaja, MD, Elisa Lucchini, MD, Francesca Romana Mauro, MD, Flavia Salvi, MD, Monia Marchetti, MD, Paola Fazi, Wilma Barcellini, MD

Blood (2017) 130 (Supplement 1): 2199.

https://doi.org/10.1182/blood.V130.Suppl_1.2199.2199

Published: 2017

Journal Articles

NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells

Mauro Di Ianni, MD PhD, Stefano Baldoni, Beatrice Del Papa, Erica Dorillo, Elisa Albi, Raffaella Giancola, Patrizia Accorsi, Isabella Screpanti, Emanuela Rosati, Paolo Di Bartolomeo, MD, Franca Falzetti, MD, Paolo Sportoletti

Blood (2017) 130 (Supplement 1): 1725.

https://doi.org/10.1182/blood.V130.Suppl_1.1725.1725

Published: 2017

Journal Articles

Modeling Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia in Transgenic Mice Using Human MYD88 L256P Mutated Protein

Tomasz Sewastianik, MSc,PhD, Maria Luisa Guerrera, MD, Meng Jiang, MD, Peter S. Dennis, Jianjun Zhao, MD, Guang Yang, PhD, Zachary Hunter, PhD, Geraldine S. Pinkus, Petr Jarolim, MD PhD, Wong Kwok-Kin, MD PhD, Steven P Treon, MDPhDFRCP, Ruben D. Carrasco, MD PhD

Blood (2017) 130 (Supplement 1): 2510.

https://doi.org/10.1182/blood.V130.Suppl_1.2510.2510

Published: 2017

Journal Articles

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Anna Amanda Schönherz, PhD, Julie Støve Bødker, PhD, Alexander Schmitz, Rasmus Froberg Brøndum, Senior Bioinformatician, Lasse Hjort Jakobsen, MSc, Marianne Tang Severinsen, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Karen Dybkær, Professor, Martin Bøgsted, Professor, Hans Erik Johnsen, MD Professor

Blood (2017) 130 (Supplement 1): 2689.

https://doi.org/10.1182/blood.V130.Suppl_1.2689.2689

Published: 2017

Journal Articles

Obinutuzumab: what is there to learn from clinical trials?

Guillaume Cartron, Hervé Watier

Blood (2017) 130 (5): 581–589.

https://doi.org/10.1182/blood-2017-03-771832

Published: 2017

Journal Articles

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy

Sophie Chauvet, Véronique Frémeaux-Bacchi, Florent Petitprez, Alexandre Karras, Laurent Daniel, Stéphane Burtey, Gabriel Choukroun, Yahsou Delmas, Dominique Guerrot, Arnaud François, Moglie Le Quintrec, Vincent Javaugue, David Ribes, Laurence Vrigneaud, Bertrand Arnulf, Jean Michel Goujon, Pierre Ronco, Guy Touchard, Frank Bridoux

Blood (2017) 129 (11): 1437–1447.

https://doi.org/10.1182/blood-2016-08-737163

Published: 2017

Includes: Supplemental data

Journal Articles

Alemtuzumab for Treatment of Refractory Evans Syndrome

Timothy O'Brien, MD

Blood (2015) 126 (23): 4542.

https://doi.org/10.1182/blood.V126.23.4542.4542

Published: 2015

Journal Articles

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Stefan Schönland, Ute Hegenbart, MD, Simona Iacobelli, Jennifer Hoek, Jakob R. Passweg, MD, Dominique Bordessoule, Jean-Henri Bourhis, MD PhD, Martin R. Schipperus, MD PhD, Theo deWitte, Laurent Garderet, MD, Nicolaus Kröger

Blood (2015) 126 (23): 4397.

https://doi.org/10.1182/blood.V126.23.4397.4397

Published: 2015

Journal Articles

Clinical and Cytogenetic Characterization of Light Chain Amyloidosis Patients with a Low Amyloidogenic Free Light Chain Count at First Diagnosis

Tobias Dittrich, MD, Ute Hegenbart, MD, Tilmann Bochtler, MD, Christoph Kimmich, MD, Anna Jauch, Prof., Arnt Kristen, MD, Hartmut Goldschmidt, MD, Anthony D. Ho, MD, Stefan Schönland, MD

Blood (2015) 126 (23): 1790.

https://doi.org/10.1182/blood.V126.23.1790.1790

Published: 2015

Journal Articles

High Prevalence of Marginal ZONE Lymphoma Among Patients with Acquired C1- Inhibtor Deficiency

Roberto Castelli, Prof, Davide Rossi, MD PhD, Arquati Massimo, Suffritti Chiara, Andrea Zanichelli, Wu Maddalena, Cicardi Marco, Prof

Blood (2015) 126 (23): 1444.

https://doi.org/10.1182/blood.V126.23.1444.1444

Published: 2015

NARROW

The Use of Next Generation Gene Sequencing to Measure Minimal Residual Disease in Patients with AL Amyloidosis and Low Plasma Cell Burden: A Feasibility Study

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

Coexistence of B-Cell Dyscrasia with Large Granular Lymphocytic Leukemia

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Single-Institution Analysis

Chimeric Antigen Receptor T-Cells for the Treatment of Gamma-Delta T-Cell Malignancies

Detection of Circulating Clonal Plasma Cells Using Next Generation Sequencing in Patients with AL Amyloidosis and Low Plasma Cell Burden: A Novel Discovery

IGHV-D-J Repertoire Analysis Obtained By High-Throughput Sequencing of CD5+ B-Cells in CLL Patients: Prognostic Markers and Disease Development Implications

Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells

Modeling Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia in Transgenic Mice Using Human MYD88 L256P Mutated Protein

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Obinutuzumab: what is there to learn from clinical trials?

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy

Alemtuzumab for Treatment of Refractory Evans Syndrome

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Clinical and Cytogenetic Characterization of Light Chain Amyloidosis Patients with a Low Amyloidogenic Free Light Chain Count at First Diagnosis

High Prevalence of Marginal ZONE Lymphoma Among Patients with Acquired C1- Inhibtor Deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only